Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC16A3 | O15427 | 6/20 | 0.68 |
| ▸ | MAOB | P27338 | 5/20 | 0.58 |
| ▸ | CA12 | O43570 | 3/20 | 0.54 |
| ▸ | CA1 | P00915 | 3/20 | 0.54 |
| ▸ | CA5A | P35218 | 3/20 | 0.54 |
| ▸ | CA7 | P43166 | 3/20 | 0.54 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.54 |
| ▸ | CA3 | P07451 | 2/20 | 0.54 |
| ▸ | CA6 | P23280 | 2/20 | 0.54 |
| ▸ | CA9 | Q16790 | 2/20 | 0.54 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.54 |
| ▸ | CA4 | P22748 | 2/20 | 0.54 |
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.53 |
| ▸ | HPGD | P15428 | 4/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.53 |
| ▸ | GAA | P10253 | 2/20 | 0.53 |
| ▸ | CA2 | P00918 | 2/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL203997 | 0.81 | SLC16A3 (1.00) | SLC16A3MAOBCA12CA1CA5A | |
| SCHEMBL838477 | 0.80 | HSD17B3 (0.56) | SLC16A3MAOBCA12CA1CA5A | |
| SCHEMBL4101829 | 0.79 | SLC16A3 (0.74) | SLC16A3MAOBCA12CA1CA5A | |
| SCHEMBL31222311 | 0.79 | SLC16A3 (0.74) | SLC16A3MAOBCA12CA1CA5A | |
| SCHEMBL93281 | 0.79 | SLC16A3 (0.70) | SLC16A3MAOBCA12CA1CA5A | |
| SCHEMBL381683 | 0.78 | NPC1 (0.67) | MAOBALDH1A1HPGDKDM4EGAA | |
| SCHEMBL1460890 | 0.78 | GLA (0.68) | SLC16A3MAOBCA12CA1CA5A | |
| SCHEMBL8933006 | 0.78 | SLC16A3 (0.70) | SLC16A3MAOBCA12CA1CA5A | |
| SCHEMBL17704676 | 0.78 | ALDH1A1 (0.75) | SLC16A3MAOBCA12CA1CA5A | |
| SCHEMBL6418716 | 0.77 | SLC16A3 (0.71) | SLC16A3MAOBCA12CA1CA5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9645153-B2 | Labeling reagents and methods of their use | Life Technologies Corporation (US) | 2017-05-09 | — | — | US | disclosed |
| US-20150355186-A1 | Labeling Reagents and Methods of Their Use | INVITROGEN CORPORATION | 2015-12-10 | — | — | US | disclosed |
| US-9140706-B2 | Labeling reagents and methods of their use | Life Technologies Corporation (US) | 2015-09-22 | — | — | US | disclosed |
| US-20130337536-A1 | Labeling Reagents and Methods of Their Use | Life Technologies Corporation (US) | 2013-12-19 | — | — | US | disclosed |
| US-8586743-B2 | Labeling reagents and methods of their use | Life Technologies Corporation (US) | 2013-11-19 | — | — | US | disclosed |
| US-8323903-B2 | Detection of preferential target in sample; obtain sample, mix with labelled antibody, detect presence of label, the presence of label indicates presence of target | Life Technologies Corporation (US) | 2012-12-04 | — | — | US | disclosed |
| US-20090004753-A1 | LABELING REAGENTS AND METHODS OF THEIR USE | INVITROGEN CORPORATION (US) | 2009-01-01 | — | — | US | disclosed |
| US-20030073149-A1 | Antibody complexes and methods for immunolabeling | Life Technologies Corporation | 2003-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150355186-A1 | Labeling Reagents and Methods of Their Use | GUSB, CES2, MRPL21 | SLC16A3 1248/4885MAOB 391/4885CA12 219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.